Introducing Markers which are Involved in COVID-19 Disease: Severe Condition Versus Mild State, a Network Analysis

Vahid Mansouri; Mostafa Rezaei-Tavirani; farshad okhovatian; Hojjat Allah Abbaszadeh

doi:10.22037/jcma.v6i4.35656

Journal of Cellular & Molecular Anesthesia

Journal Information Editors & Boards Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement New Publisher Announcement Reviewer and AE Registration Form Contact Us Support

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v6i4.35656

Introducing Markers which are Involved in COVID-19 Disease: Severe Condition Versus Mild State, a Network Analysis

Author(s):

Vahid Mansouri

^,*,

Mostafa Rezaei-Tavirani

¹,

farshad okhovatian

²,

Hojjat Allah Abbaszadeh

³

1Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2Physiotherapy Research Center, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3Laser Application in Medical Sciences Research Center, Shohada-e-Tajrish Hospital, Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Journal of Cellular & Molecular Anesthesia:Vol. 6, issue 4; e149740

Article type:Original Articles

How to Cite:Vahid MansouriMostafa Rezaei-Taviranifarshad okhovatianHojjat Allah AbbaszadehIntroducing Markers which are Involved in COVID-19 Disease: Severe Condition Versus Mild State, a Network Analysis.J Cell Mol Anesth.6(4):e149740.https://doi.org/10.22037/jcma.v6i4.35656.

Abstract

Background: Coronavirus disease 2019 (COVID-19) had a pandemic spread worldwide. Most infected patients had a good prognosis, but some developed severe illnesses, which led to fatalities. It is urgent to define markers that reveal the severity of the disease. This study aimed to introduce the main plasma protein biomarkers involved in severe conditions versus mild infection states. Materials and Methods: A total of 91 significant differentially expressed proteins (DEPs) in the sera of the patients with the severe condition versus mild states were extracted from an original article. The protein interaction is included in a network designed via STRING database and Cytoscape software to find the critical proteins which differentiate severe conditions versus mild states. Results: A total of 6 hub nodes identified as critical target proteins were APOB, SERPINA1, CP, ORM1, HASPA8, and VW, according to the Degree value of nodes. Conclusion: The expression of different biomarkers in the sera of COVID-19 patients can be considered differential markers that separate severe conditions from mild states; however, a more thorough investigation is required. Keywords: COVID-19, Protein, Plasma, Biomarker, Network analysis ?

Keywords

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Vahid Mansouri:[PubMed][Scholar]
Mostafa Rezaei-Tavirani:[PubMed][Scholar]
farshad okhovatian:[PubMed][Scholar]
Hojjat Allah Abbaszadeh:[PubMed][Scholar]